News

Sanders and Cummings Request Pricing Info From PTC Therapeutics for Critical Drug

Washington, D.C. (Mar. 22, 2017)—Today, Sen. Bernie Sanders (I-Vt.) and Rep. Elijah E. Cummings (D-Md.), Ranking Member of the House Committee on Oversight and Government Reform, requested information from PTC Therapeutics, Inc. about the price they intend to charge for the brand name version of deflazacourt, a drug used to treat a deadly genetic muscle deterioration disorder. PTC recently purchased the medication from Marathon Pharmaceuticals.

Cummings Issues Statement After Classified Briefing on Recent Secret Service Incidents

Washington, D.C. (March 20, 2017)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement after receiving a classified briefing about recent security incidents involving the U.S. Secret Service from Department of Homeland Security Secretary John F. Kelly and Secret Service Acting Director William Callahan:

Bipartisan Postal Reform Bill Passes Through Committee

WASHINGTON - Today, with a bipartisan voice vote, the House Oversight and Government Reform Committee approved H.R.

Cummings Condemns Trump's FY2018 Budget

Washington, D.C. (Mar. 16, 2017)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement on President Donald Trump's FY2018 Budget:

Maloney, Cummings, and Kelly Request Hearing on Bipartisan Gun Trafficking Legislation

Washington, DC (Mar. 16, 2017)—Today, Reps. Carolyn Maloney (D-NY), Elijah E.

Cummings Releases New Documents Confirming That Flynn Received Funds From Instrument of Russian Government

Cummings Seeks Flynn's Security Clearance Documents and Calls on Pentagon to Address Emoluments Clause Violation

Sanders, Cummings Investigate Unusual Circumstances Surrounding FDA Approval of Muscular Dystrophy Drug

WASHINGTON, March 15 – Sen. Bernie Sanders (I-Vt.) and Rep. Elijah E. Cummings (D-Md.), ranking member of the House Committee on Oversight and Government Reform, sent a letter to the Food and Drug Administration Wednesday requesting information about the unusual circumstances surrounding the approval of Emflaza – a brand name version of a drug used to treat a deadly genetic muscle deterioration disorder.

Cummings Condemns GOP Health Repeal Bill After CBO Report Finds 14 Million Would Lose Health Coverage Next Year

Washington, D.C. (March 13, 2017)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement after the nonpartisan Congressional Budget Office (CBO) released a report concluding that 14 million Americans would lose health insurance coverage in 2018 if Republicans pass their bill to repeal the Affordable Care Act: